Rauch, T. (2010). Efficacy and safety of linagliptin (BI 1356), a novel inhibitor of dipeptidyl-peptidase 4 (DPP-4), in animal models and clinical studies in healthy volunteers and patients with type 2 diabetes mellitus.
Chicago-Zitierstil (17. Ausg.)Rauch, Thomas. Efficacy and Safety of Linagliptin (BI 1356), a Novel Inhibitor of Dipeptidyl-peptidase 4 (DPP-4), in Animal Models and Clinical Studies in Healthy Volunteers and Patients with Type 2 Diabetes Mellitus. 2010.
MLA-Zitierstil (9. Ausg.)Rauch, Thomas. Efficacy and Safety of Linagliptin (BI 1356), a Novel Inhibitor of Dipeptidyl-peptidase 4 (DPP-4), in Animal Models and Clinical Studies in Healthy Volunteers and Patients with Type 2 Diabetes Mellitus. 2010.
Achtung: Diese Zitate sind unter Umständen nicht zu 100% korrekt.